Status:
RECRUITING
Advanced Imaging Holistic Omics Biobank
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Oncologic Disorders
Neurologic Disorder
Eligibility:
All Genders
18+ years
Brief Summary
Imaging methods today represent the pillar of prevention, diagnosis, patients monitoring and treatment. Improvement in technology led the development of increasingly high-performance scanners whose po...
Detailed Description
The present study is a observational prospective single center study aimed to build a large-scale multiomic database of patients submitted to advanced imaging study performed Photon Counting TC (Neaot...
Eligibility Criteria
Inclusion
- Adult subjects (\>18 y.o.) submitted to Computed Tomography (CT) using Photon Counting CT scanner (Neaotom Alpha, Siemens) and Magnetic Resonance (MRI) exams acquired with 3T scanner (MR 7700, Philips) for examination required for clinical practice or for clinical trials at the IRCCS San Raffaele Hospital who signe an Informed Consent authorizing data collection.
Exclusion
- Absent informed consent signed
Key Trial Info
Start Date :
September 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 15 2034
Estimated Enrollment :
50000 Patients enrolled
Trial Details
Trial ID
NCT06523270
Start Date
September 15 2024
End Date
September 15 2034
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele
Milan, Italy, 20132